Phenixfin Net Worth
Phenixfin Net Worth Breakdown | PFX |
Phenixfin Net Worth Analysis
Phenixfin's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Phenixfin's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Phenixfin's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Phenixfin's net worth analysis. One common approach is to calculate Phenixfin's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Phenixfin's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Phenixfin's net worth. This approach calculates the present value of Phenixfin's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Phenixfin's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Phenixfin's net worth. This involves comparing Phenixfin's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Phenixfin's net worth relative to its peers.
Enterprise Value |
|
To determine if Phenixfin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Phenixfin's net worth research are outlined below:
| Phenixfin is way too risky over 90 days horizon | |
| Phenixfin appears to be risky and price may revert if volatility continues | |
| Phenixfin has about 24.38 M in cash with (20.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.1. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 6934 shares by Amster Howard of Phenixfin subject to Rule 16b-3 |
Phenixfin Quarterly Good Will |
|
Phenixfin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Phenixfin. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Phenixfin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Know Phenixfin's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Phenixfin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Phenixfin backward and forwards among themselves. Phenixfin's institutional investor refers to the entity that pools money to purchase Phenixfin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2024-06-30 | 401 | Wells Fargo & Co | 2024-06-30 | 261 | Archer Investment Corporation | 2024-09-30 | 126 | Main Street Group Ltd | 2024-06-30 | 50.0 | Manning & Napier Advisors, Llc | 2024-06-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | Northwestern Mutual Wealth Management Co | 2024-06-30 | 0.0 | Adalta Capital Management Llc | 2024-09-30 | 149.6 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 132.6 K | 22nw, Lp | 2024-06-30 | 117.9 K | American Financial Group Inc | 2024-09-30 | 64.3 K |
Follow Phenixfin's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 94.42 M.Market Cap |
|
Project Phenixfin's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.14 | |
| Return On Capital Employed | 0.06 | 0.07 | |
| Return On Assets | 0.13 | 0.14 | |
| Return On Equity | 0.21 | 0.22 |
When accessing Phenixfin's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Phenixfin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Phenixfin's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Phenixfin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phenixfin. Check Phenixfin's Beneish M Score to see the likelihood of Phenixfin's management manipulating its earnings.
Evaluate Phenixfin's management efficiency
Phenixfin has Return on Asset of 0.0325 % which means that on every $100 spent on assets, it made $0.0325 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.135 %, implying that it generated $0.135 on every 100 dollars invested. Phenixfin's management efficiency ratios could be used to measure how well Phenixfin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.14 in 2024. Return On Capital Employed is likely to rise to 0.07 in 2024. At this time, Phenixfin's Intangible Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 188.4 M in 2024, whereas Total Assets are likely to drop slightly above 204.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 80.63 | 76.60 | |
| Tangible Book Value Per Share | 80.63 | 76.60 | |
| Enterprise Value Over EBITDA | 4.38 | 4.60 | |
| Price Book Value Ratio | 0.62 | 0.59 | |
| Enterprise Value Multiple | 4.38 | 4.60 | |
| Price Fair Value | 0.62 | 0.59 | |
| Enterprise Value | 181.5 M | 172.4 M |
The strategic decisions made by Phenixfin management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Enterprise Value Revenue 6.0536 | Revenue 22.3 M | Quarterly Revenue Growth 0.289 | Revenue Per Share 10.843 | Return On Equity 0.135 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phenixfin insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phenixfin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phenixfin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Phenixfin Corporate Filings
F4 | 22nd of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 6th of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 11th of July 2024 Other Reports | ViewVerify | |
F3 | 5th of March 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Phenixfin Earnings per Share Projection vs Actual
Phenixfin Corporate Management
| Ryan Phalen | Managing Director | Profile | |
| Gerald Cummins | Chief Officer | Profile | |
| Benjamin Tilewick | Senior Analyst | Profile | |
| Chris Cannellos | Controller | Profile | |
| Ellida CPA | Chief Officer | Profile | |
| Therese Dyman | Controller | Profile |
Additional Tools for Phenixfin Stock Analysis
When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.